Sanofi SA (ADR)  

(Public, NYSE:SNY)   Watch this stock  
Find more results for SNY
45.94
+1.85 (4.20%)
Real-time:   3:38PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 45.72 - 46.16
52 week 36.81 - 46.16
Open 46.11
Vol / Avg. 3.62M/1.33M
Mkt cap 116.94B
P/E 25.26
Div/yield 1.58/3.43
EPS 1.82
Shares 1.27B
Beta 0.95
Inst. own 22%

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 8.31% 12.54%
Operating margin 11.75% 17.42%
EBITD margin - 29.82%
Return on average assets - 4.20%
Return on average equity - 7.60%
Employees 106,859 -
CDP Score - A-

Address

54 rue la Boetie
PARIS, 75008
France
+33-1-53774000 (Phone)
+33-1-53774463 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company's segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme.

Officers and directors

Serge Weinberg Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Olivier Brandicourt Chairman of the Executive Committee, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Jerome Contamine Executive Vice President, Chief Financial Officer, Member of the Executive Committee and the Senior Leadership Team
Age: 58
Bio & Compensation  - Reuters
Karen Marie Linehan Executive Vice President, Legal Affairs and General Counsel, Member of the Executive Committee and the Senior Leadership Team
Age: 57
Bio & Compensation  - Reuters
Olivier Charmeil Executive Vice President and General Manager, General Medicines & Emerging Markets, Member of the Executive Committee and the Senior Leadership Team
Age: 53
Bio & Compensation  - Reuters
Peter Guenter Executive Vice President and General Manager, Diabetes & Cardiovascular, Member of the Executive Committee and the Senior Leadership Team
Age: 54
Bio & Compensation  - Reuters
Carsten Hellmann Executive Vice President and General Manager of Merial, Member of the Executive Committee and the Senior Leadership Team
Age: 52
Bio & Compensation  - Reuters
David Loew Executive Vice President and General Manager of Sanofi Pasteur, Member of the Executive Committee and the Senior Leadership Team
Bio & Compensation  - Reuters
David P. Meeker M.D. Executive Vice President and General Manager of Sanofi Genzyme, Member of the Executive Committee and the Senior Leadership Team
Bio & Compensation  - Reuters
Roberto Pucci Executive Vice President, Human Resources, Member of the Executive Committee and the Senior Leadership Team
Age: 52
Bio & Compensation  - Reuters